CORE Biomedicine
CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
$21M Series A ·
Led by Elikon Venture · Source: vcnewsdaily.com
Funding history ↓Signals
Website registeredOct 12, 2022 (4 years old)
Funding rounds
- Series A · $21MEElikon Venture (lead),
UUTokyo Innovation Platform (lead),
BBioVenture,
CCD Capital, IInnoPinnacle Fund,
MMitsubishi UFJ Capital,
RRoot Ventures,
SSuzhou Innovation Investment Group,
VVision Incubate
Source: vcnewsdaily.com - Website created
Founders and team
GZ
Guo Zheng FounderPZ
Ping Zhu FounderTS
Tarek Sahmoud Chief Medical Officer
Investors
AAMED
BBioVenture
CCD Capital
- EElikon Venturelead investor
- IInnoPinnacle Fund
MMitsubishi UFJ Capital
RRoot Ventures
SSuzhou Innovation Investment Group
UUTokyo Innovation Platformlead investor
VVision Incubate
Companies like CORE Biomedicine
GGalvanisPre Seed · May 2026
IIktos$16M Series A · Mar 2023
PPathos$237M Series B+ · Oct 2026
AAqemia$38M Series A · Dec 2024
VVillanelle LifeSeed · Jul 2026
EElement Biosciences$175M Series B+ · Jun 2026
Other companies backed by Elikon Venture
AAngitia Bio$130M Series B+ · Feb 2026
AAllorion Therapeutics$50M Series B+ · Mar 2023
OOricell TherapeuticsSeries B+ · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/core-biomedicine (get a free API key).